Bionics

https://atonra.wirdneu.de/storage/assets/header/bionics.jpg

Marketing communication

Advanced care, better health, lower costs

Innovations in the fields of medicine, artificial intelligence, robotics and sensors are finally giving a new life to medical technologies and are making human enhancement a reality.


Theme Description

Bionics, which is taking on human body dysfunctions and disabilities and, more globally, helping improve the wellness and lifespan of the world population, benefits from long-term drivers:

  • an ageing world population and a shortage of donated organs,

  • major technology breakthroughs leading to an impressive product pipeline,

  • an improving outlook for the reimbursement of bionic devices by insurers or health agencies.

The investment universe encompasses next-generation prosthetics, medical wearables and devices, surgical and medical robots, exoskeletons, 3D printing and artificial intelligence all play a major role in the emergence of bionics.

Performances

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec annual

Statistics

Characteristics

Holdings & Breakdowns

Geographical Breakdown
Industry Exposure

Potential Risks

No specific risks information available for this fund's theme.

Price: 08-Dec-2025

121.86

Select the related product:

  • Asset class
    EQUITY
  • Inception date
    12-Feb-2019
  • Currency
    US Dollar ($)
  • ISIN
    XS1668100602
  • Ticker
    JMLNA2BN
  • Issue price
    100.00
  • Last price
    121.86

YTD performance

3.37 %

Login

Create an account

By creating an account you agree to our User Agreement, Privacy Policy and to receive related communications.

Reset password

Type in your e-mail and reset instructions will be sent to you.